Insider holders · CIK 0001042074
CymaBay Therapeutics, Inc. · CBAY
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Evan A. SteinDirector | 151,880 | — | 151,880 | Apr 28, 2016 · 6:45 pm EDT | Form 3/A |
| Sujal ShahChief Executive Officer | 110,000 | — | 110,000 | Dec 21, 2018 · 5:11 pm EST | Form 4 |
| Kurt Von EmsterDirector | 90,000 | 18,316 | 108,316 | Dec 19, 2018 · 4:18 pm EST | Form 4 |
| Kurt von EmsterDirector | 90,000 | 17,326 | 107,326 | Aug 17, 2015 · 5:27 pm EDT | Form 4 |
| Robert James WillsDirector | 30,000 | — | 30,000 | Aug 2, 2017 · 8:21 am EDT | Form 4 |
| Charles McWherterSVP & Chief Scientific Officer | 15,000 | — | 15,000 | Nov 6, 2017 · 8:43 pm EST | Form 4 |
| Harold Van WartPresident and CEO | 7,958 | — | 7,958 | May 19, 2015 · 7:44 pm EDT | Form 4 |
| Patrick J. OMaraVP, Business Development | 5,022 | — | 5,022 | Apr 19, 2016 · 7:56 am EDT | Form 4 |
| Daniel MenoldVice President, Finance | 0 | — | 0 | Aug 31, 2018 · 7:24 pm EDT | Form 4 |
| Carl GoldfischerDirector | 0 | 0 | 0 | Feb 8, 2019 · 8:21 pm EST | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.